IP Library Granted Patent US 12,502,542
Granted Patent B2
US 12,502,542 · App. 17/049,881 · Granted Dec 23, 2025

Devices, systems, and methods for treating urinary and fecal incontinence

Inventors: Marc D. Beer (Sudbury, MA); Jose Bohorquez (Boston, MA); Samantha J. Pulliam (Boston, MA); Jessica L. McKinney (Boston, MA)
Assignee: Axena Health, Inc.
A61N1/36135A61N1/36007A61N1/3606A61N1/37247A61B5/1104A61B5/202A61B5/6847A61B2562/0219A61B2562/028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,542
App. No.
17/049,881
Granted
Dec 23, 2025
Kind
B2
Abstract

Featured are intravaginal devices and electrical stimulation devices, systems, thereof, and methods of using the devices and systems thereof to observe pelvic floor movements in order to diagnose, treat, or prevent urinary and fecal incontinence disorders (e.g., urge incontinence) and their accompanying symptoms or to diagnose and/or improve the efficacy of neuromodulation therapy.

Claims (60)

1 . A method of treating urinary or fecal incontinence in a subject comprising:

a) providing a system comprising an intravaginal device comprising a plurality of accelerometers located along a length of the device; and a medical device comprising an implantable lead configured to deliver electrical stimulation to a sacral nerve;

b)

i) inserting the intravaginal device into a vagina of the subject, and

ii) placing the implantable lead on the sacral nerve of the subject and electrically stimulating the sacral nerve with the medical device;

c) obtaining and visualizing on a graphical user interface positional data from the accelerometers of the intravaginal device during the electrical stimulation of the sacral nerve, wherein a position of the accelerometers on the graphical user interface is a representation of a position of the vagina during movement of one or more pelvic floor muscles of the subject resulting from the electrical stimulation of the sacral nerve; and

d) repeating steps b) ii) and c) one or more times to optimize the placement of the implantable lead to increase efficacy of the electrical stimulation.

2 . The method of claim 1 , further comprising processing the positional data from the accelerometers to determine an occurrence of the movement of the one or more pelvic floor muscles.

3 . The method of claim 2 , further comprising employing the processed positional data to provide feedback to the medical device regarding the movement of the one or more pelvic floor muscles or wherein the medical device is activated to stimulate the sacral nerve based on feedback from the intravaginal device or the medical device.

4 . The method of claim 3 , wherein the feedback is determined from the positional data of the accelerometers of the intravaginal device.

5 . The method of claim 1 , wherein the accelerometers are microelectromechanical (MEM) accelerometers.

6 . The method of claim 1 , wherein the intravaginal device comprises:

i) a main body having an outer edge configured to contact a vaginal wall or vaginal fornix and an internal diameter sized to encircle a cervix or vaginal cuff; and

ii) a tether connected to the main body.

7 . The method of claim 6 , wherein the tether comprises 2 to 10 of the accelerometers or wherein the main body comprises 2 to 6 of the accelerometers.

8 . The method of claim 6 , wherein:

a) the main body has a horseshoe form or cup-shaped form;

b) the main body comprises at least one of the accelerometers;

c) one of the accelerometers is shared by the main body and the tether;

d) a length of the tether is about 3 cm to about 50 cm;

e) a circumference of the main body is about 10 cm to about 50 cm; or

f) the intravaginal device comprises two or more accelerometers on the tether and wherein the accelerometers are separated on the tether by a distance of about 0.5 cm to about 5 cm.

9 . The method of claim 8 , wherein:

i) the length of the tether is about 25.5 cm;

ii) the circumference of the main body is about 27 cm; or

iii) the distance between the accelerometers on the tether is about 1.6 cm.

10 . The method of claim 1 , wherein the intravaginal device comprises a transmitter or receiver for communicating data to an electronic device or to the medical device; or the implantable lead comprises one or more collapsible projections configured to anchor the lead to surrounding tissue.

11 . The method of claim 10 , wherein:

i) the transmitter or receiver is a radio frequency transmitter or receiver;

ii) the transmitter or receiver can wirelessly communicate the data to the electronic device or to the medical device;

iii) the transmitter or receiver are configured for use with a Bluetooth or Wi-Fi enabled electronic device;

iv) the electronic device comprises a display, wherein optionally, the display is on the graphical user interface, wherein, optionally, the graphical user interface comprises a touch user interface;

v) the electronic device is a computer, tablet, smartphone, or smart watch; or

vi) the collapsible projections are tines.

12 . The method of claim 1 , wherein:

i) the intravaginal device or the medical device comprises a battery;

ii) the medical device comprises a processor configured to receive input from a user; or

iii) the medical device comprises a transmitter or receiver for communicating data to the electronic device or to the intravaginal device.

13 . The method of claim 12 , wherein:

a) the transmitter or receiver of the medical device is a radio frequency transmitter or receiver;

b) the transmitter or receiver of the medical device can wirelessly communicate the data to the electronic device or to the intravaginal device; or

c) the transmitter or receiver of the medical device are configured for use with a Bluetooth or Wi-Fi enabled electronic device.

14 . The method of claim 1 , wherein the medical device:

i) comprises one or more electrodes;

ii) comprises a pulse generator;

iii) comprises two or more implantable leads; or

iv) generates or modulates an electrical signal in response to an input signal from the intravaginal device.

15 . A method of detecting proper placement of an implantable lead of a medical device configured to deliver electrical stimulation to a sacral nerve of a subject comprising:

a) providing a system comprising an intravaginal device comprising a plurality of accelerometers located along a length of the device; and the medical device comprising an implantable lead configured to deliver electrical stimulation to the sacral nerve;

b) inserting the intravaginal device into a vagina of the subject and placing the implantable lead on the sacral nerve of the subject and electrically stimulating the sacral nerve with the medical device;

c) obtaining and visualizing on a graphical user interface positional data from the accelerometers of the intravaginal device during the electrical stimulation of the sacral nerve, wherein a position of the accelerometers on the graphical user interface is a representation of a position of the vagina during movement of one or more pelvic floor muscles of the subject resulting from the electrical stimulation of the sacral nerve;

d) processing the positional data from the accelerometers to determine an occurrence of a pelvic floor movement; and

e) determining that the implantable lead of the medical device is properly placed in the sacral nerve of the subject based on the occurrence of the pelvic floor movement detected by the intravaginal device in step d).

16 . The method of claim 15 , further comprising treating the subject for urinary or fecal incontinence by repeatedly administering electrical stimulation to the sacral nerve of the subject with the medical device.

17 . A method of identifying a subject as responsive to treatment for urinary or fecal incontinence with a medical device configured to deliver electrical stimulation to a sacral nerve of the subject comprising:

a) providing a system comprising an intravaginal device comprising a plurality of accelerometers located along a length of the device; and the medical device comprising an implantable lead configured to deliver electrical stimulation to the sacral nerve;

b) inserting the intravaginal device into a vagina of the subject and placing the implantable lead on the sacral nerve of the subject and electrically stimulating the sacral nerve with the medical device;

c) obtaining and visualizing on a graphical user interface positional data from the accelerometers of the intravaginal device during the electrical stimulation of the sacral nerve, wherein a position of the accelerometers on the graphical user interface is a representation of a position of the vagina during movement of one or more pelvic floor muscles of the subject resulting from the electrical stimulation of the sacral nerve;

d) processing the positional data from the accelerometers to determine an occurrence of a pelvic floor movement; and

e) determining the subject to be responsive to the treatment with the medical device based on the occurrence of the pelvic floor movement detected by the intravaginal device in step d).

Assignments (3)
SECURITY INTEREST Recorded Dec 23, 2025
From: AXENA HEALTH, INC.
To: ANKURA TRUST COMPANY, LLC, ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 073305/0470 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2023
From: RENOVIA INC.
To: AXENA HEALTH, INC.
Reel/Frame 064632/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: BEER, MARC D.; BOHORQUEZ, JOSE; PULLIAM, SAMANTHA J.; MCKINNEY, JESSICA L.
To: RENOVIA INC.
Reel/Frame 054168/0001 →
Continuity (2)
Provisional Application 62663844 · Apr 27, 2018
Related Publication 20210069513A1 · Mar 11, 2021
References Cited (332)
US 2830582A · Ljung · 1958 [cited by applicant]
US 3854476A · Dickinson, III et al. · 1974 [cited by applicant]
US 4669478A · Robertson · 1987 [cited by applicant]
US 4873990A · Holmes et al. · 1989 [cited by applicant]
US D309866S · Fukuda et al. · 1990 [cited by applicant]
US D310275S · Su · 1990 [cited by applicant]
US 5049132A · Shaffer et al. · 1991 [cited by applicant]
US 5328077A · Lou · 1994 [cited by applicant]
US 5386836A · Biswas · 1995 [cited by applicant]
US 5406961A · Artal · 1995 [cited by applicant]
US 5562717A · Tippey et al. · 1996 [cited by applicant]
US 5603685A · Tutrone, Jr. · 1997 [cited by applicant]
US 5674238A · Sample et al. · 1997 [cited by applicant]
US 5924984A · Rao · 1999 [cited by applicant]
US 6001060A · Churchill et al. · 1999 [cited by applicant]
US 6021781A · Thompson et al. · 2000 [cited by applicant]
US 6039701A · Sliwa et al. · 2000 [cited by applicant]
US 6056699A · Sohn et al. · 2000 [cited by applicant]
US 6080118A · Blythe · 2000 [cited by applicant]
US 6086549A · Neese et al. · 2000 [cited by applicant]
US 6264582B1 · Remes · 2001 [cited by applicant]
US 6272371B1 · Shlomo · 2001 [cited by applicant]
US D458681S · Sherlock et al. · 2002 [cited by applicant]
US 6413206B2 · Biswas · 2002 [cited by applicant]
US 6432037B1 · Eini et al. · 2002 [cited by applicant]
US 6511427B1 · Sliwa, Jr. et al. · 2003 [cited by applicant]
US 6652565B1 · Shimada et al. · 2003 [cited by applicant]
US 6672996B2 · Ross et al. · 2004 [cited by applicant]
US 6679854B2 · Honda et al. · 2004 [cited by applicant]
US 6741895B1 · Gafni et al. · 2004 [cited by applicant]
US D491079S · Lim · 2004 [cited by applicant]
US D491274S · Dubniczki et al. · 2004 [cited by applicant]
US 6816744B2 · Garfield et al. · 2004 [cited by applicant]
US 7079882B1 · Schmidt · 2006 [cited by applicant]
US 7104950B2 · Levy · 2006 [cited by applicant]
US D535203S · Chen · 2007 [cited by applicant]
US D548359S · Illein et al. · 2007 [cited by applicant]
US 7577476B2 · Hochman et al. · 2009 [cited by applicant]
US 7608037B2 · Levy · 2009 [cited by applicant]
US 7628744B2 · Hoffman et al. · 2009 [cited by applicant]
US 7645220B2 · Hoffman et al. · 2010 [cited by applicant]
US 7736298B2 · Guerquin et al. · 2010 [cited by applicant]
US 7837682B2 · Ostrovsky et al. · 2010 [cited by applicant]
US 7892179B2 · Rieth · 2011 [cited by applicant]
US 7955241B2 · Hoffman et al. · 2011 [cited by applicant]
US 7957794B2 · Hochman et al. · 2011 [cited by applicant]
US D651531S · Rothman · 2012 [cited by applicant]
US 8147429B2 · Mittal et al. · 2012 [cited by applicant]
US 8360954B2 · Kim · 2013 [cited by applicant]
US 8623004B2 · Johnson et al. · 2014 [cited by applicant]
US 8715204B2 · Webster et al. · 2014 [cited by applicant]
US 8728140B2 · Feemster et al. · 2014 [cited by applicant]
US 8740767B2 · Rosen et al. · 2014 [cited by applicant]
US 8751003B2 · DiUbaldi · 2014 [cited by examiner]
US 8805472B2 · Iglesias · 2014 [cited by applicant]
US 8821407B2 · Kirsner · 2014 [cited by applicant]
US 8914111B2 · Haessler · 2014 [cited by applicant]
US 8983627B2 · Pelger et al. · 2015 [cited by applicant]
US 9155885B2 · Wei et al. · 2015 [cited by applicant]
US 9248285B2 · Haessler · 2016 [cited by applicant]
US D759813S · Newman et al. · 2016 [cited by applicant]
US D759814S · Newman et al. · 2016 [cited by applicant]
US 9381351B2 · Haessler · 2016 [cited by applicant]
US 9408685B2 · Hou et al. · 2016 [cited by applicant]
US 9656067B2 · Pelger et al. · 2017 [cited by applicant]
US D800898S · Sanders et al. · 2017 [cited by applicant]
US 9861316B2 · Egorov · 2018 [cited by applicant]
US 9970923B2 · Sturman et al. · 2018 [cited by applicant]
US 9974635B2 · Rosen et al. · 2018 [cited by applicant]
US D832437S · Zeltwanger et al. · 2018 [cited by applicant]
US D841155S · McMenamin et al. · 2019 [cited by applicant]
US D845478S · Luke · 2019 [cited by applicant]
US D846120S · Wallis et al. · 2019 [cited by applicant]
US D852069S · Fu · 2019 [cited by applicant]
US D853035S · Moretti · 2019 [cited by applicant]
US D855825S · Parsons et al. · 2019 [cited by applicant]
US 10470862B2 · Iglesias · 2019 [cited by applicant]
US 10517538B2 · Burnett et al. · 2019 [cited by applicant]
US D877895S · Sanders et al. · 2020 [cited by applicant]
US D888949S · Beer et al. · 2020 [cited by applicant]
US D889649S · Beer et al. · 2020 [cited by applicant]
US D893026S · Leather · 2020 [cited by applicant]
US D896958S · Beer et al. · 2020 [cited by applicant]
US D896959S · Beer et al. · 2020 [cited by applicant]
US D897530S · Beer et al. · 2020 [cited by applicant]
US D898911S · Beer et al. · 2020 [cited by applicant]
US D899593S · Beer et al. · 2020 [cited by applicant]
US D903853S · Wiegerinck · 2020 [cited by applicant]
US D903896S · Tianhao et al. · 2020 [cited by applicant]
US D908160S · Sun · 2021 [cited by applicant]
US D909679S · Chen · 2021 [cited by applicant]
US D910851S · Lagrange et al. · 2021 [cited by applicant]
US D918390S · Ollivier · 2021 [cited by applicant]
US D919083S · Lee · 2021 [cited by applicant]
US D923806S · Bunger von Wurmb et al. · 2021 [cited by applicant]
US D923876S · Hasegawa · 2021 [cited by applicant]
US 11135085B2 · Mikkonen et al. · 2021 [cited by applicant]
US D938581S · Floyd et al. · 2021 [cited by applicant]
US 11266343B2 · Iglesias · 2022 [cited by applicant]
US D956229S · Beer et al. · 2022 [cited by applicant]
US D958987S · Beer et al. · 2022 [cited by applicant]
US 11426625B2 · Iglesias et al. · 2022 [cited by applicant]
US 11426626B2 · Beer et al. · 2022 [cited by applicant]
US 12138019B2 · Beer et al. · 2024 [cited by applicant]
US 12220345B2 · Beer et al. · 2025 [cited by applicant]
US 12263006B2 · Iglesias · 2025 [cited by applicant]
US 12295732B2 · Beer et al. · 2025 [cited by applicant]
US 12311228B2 · Iglesias et al. · 2025 [cited by applicant]
US 20010001125A1 · Schulman et al. · 2001 [cited by applicant]
US 20010047132A1 · Johnson et al. · 2001 [cited by applicant]
US 20020022836A1 · Goble et al. · 2002 [cited by applicant]
US 20020111586A1 · Mosel et al. · 2002 [cited by applicant]
US 20020143275A1 · Sarvazyan et al. · 2002 [cited by applicant]
US 20030028180A1 · Franco · 2003 [cited by applicant]
US 20030087734A1 · Kring et al. · 2003 [cited by applicant]
US 20040236223A1 · Barnes et al. · 2004 [cited by applicant]
US 20040260207A1 · Eini et al. · 2004 [cited by applicant]
US 20050148447A1 · Nady · 2005 [cited by applicant]
US 20050177067A1 · Tracey et al. · 2005 [cited by applicant]
US 20050256423A1 · Kirsner · 2005 [cited by applicant]
US 20060036188A1 · Hoffman et al. · 2006 [cited by applicant]
US 20060074289A1 · Adler et al. · 2006 [cited by applicant]
US 20060084848A1 · Mitchnick · 2006 [cited by applicant]
US 20060211911A1 · Jao et al. · 2006 [cited by applicant]
US 20070066880A1 · Lee et al. · 2007 [cited by applicant]
US 20070185417A1 · Mittal · 2007 [cited by examiner]
US 20070232882A1 · Glossop et al. · 2007 [cited by applicant]
US 20070255090A1 · Addington et al. · 2007 [cited by applicant]
US 20070265675A1 · Lund et al. · 2007 [cited by applicant]
US 20070270686A1 · Ritter et al. · 2007 [cited by applicant]
US 20080077053A1 · Epstein et al. · 2008 [cited by applicant]
US 20080139876A1 · Kim · 2008 [cited by applicant]
US 20080146941A1 · Dala-Krishna · 2008 [cited by applicant]
US 20080149109A1 · Ziv · 2008 [cited by applicant]
US 20080154131A1 · Lee et al. · 2008 [cited by applicant]
US 20080171950A1 · Franco · 2008 [cited by applicant]
US 20080300658A1 · Meskens · 2008 [cited by applicant]
US 20090024001A1 · Parks et al. · 2009 [cited by applicant]
US 20090149740A1 · Hoheisel · 2009 [cited by applicant]
US 20090216071A1 · Zipper · 2009 [cited by applicant]
US 20090231125A1 · Baldus et al. · 2009 [cited by applicant]
US 20090270963A1 · Pelger et al. · 2009 [cited by applicant]
US 20090306509A1 · Pedersen et al. · 2009 [cited by applicant]
US 20100069784A1 · Blaivas · 2010 [cited by applicant]
US 20100174218A1 · Shim · 2010 [cited by applicant]
US 20100222708A1 · Hitchcock et al. · 2010 [cited by applicant]
US 20100249576A1 · Askarinya et al. · 2010 [cited by applicant]
US 20100262049A1 · Novak et al. · 2010 [cited by applicant]
US 20100277280A1 · Burkart et al. · 2010 [cited by applicant]
US 20100298895A1 · Ghaffari et al. · 2010 [cited by applicant]
US 20100315225A1 · Teague · 2010 [cited by applicant]
US 20110054357A1 · Egorov et al. · 2011 [cited by applicant]
US 20110077500A1 · Shakiba · 2011 [cited by applicant]
US 20110144458A1 · Gauta · 2011 [cited by applicant]
US 20110190580A1 · Bennett et al. · 2011 [cited by applicant]
US 20110190595A1 · Bennett et al. · 2011 [cited by applicant]
US 20110196263A1 · Egorov et al. · 2011 [cited by applicant]
US 20110264163A1 · Tracey · 2011 [cited by examiner]
US 20120016258A1 · Webster et al. · 2012 [cited by applicant]
US 20120245490A1 · Fausett et al. · 2012 [cited by applicant]
US 20120265044A1 · Broens · 2012 [cited by applicant]
US 20120265049A1 · Iglesias · 2012 [cited by applicant]
US 20130035611A1 · White · 2013 [cited by applicant]
US 20130053627A1 · Bercovich et al. · 2013 [cited by applicant]
US 20130130871A1 · McCoy et al. · 2013 [cited by applicant]
US 20130144191A1 · Egorov et al. · 2013 [cited by applicant]
US 20130184567A1 · Xie et al. · 2013 [cited by applicant]
US 20130192606A1 · Ziv et al. · 2013 [cited by applicant]
US 20130204313A1 · Addington · 2013 [cited by examiner]
US 20130237771A1 · Runkewitz et al. · 2013 [cited by applicant]
US 20130324380A1 · Horsley · 2013 [cited by applicant]
US 20140066813A1 · Daly et al. · 2014 [cited by applicant]
US 20140073879A1 · Cantor et al. · 2014 [cited by applicant]
US 20140088471A1 · Leivseth et al. · 2014 [cited by applicant]
US 20140155225A1 · Sedic · 2014 [cited by applicant]
US 20140213927A1 · Webster et al. · 2014 [cited by applicant]
US 20140275743A1 · Rosen et al. · 2014 [cited by applicant]
US 20140288612A1 · Addington · 2014 [cited by examiner]
US 20140296705A1 · Iglesias · 2014 [cited by applicant]
US 20140309550A1 · Iglesias · 2014 [cited by applicant]
US 20150032030A1 · Iglesias · 2015 [cited by applicant]
US 20150112230A1 · Iglesias · 2015 [cited by applicant]
US 20150112231A1 · Iglesias · 2015 [cited by applicant]
US 20150133832A1 · Courtion et al. · 2015 [cited by applicant]
US 20150196802A1 · Siegel · 2015 [cited by applicant]
US 20150257695A1 · Addington et al. · 2015 [cited by applicant]
US 20150282763A1 · Rosenshein · 2015 [cited by applicant]
US 20160008664A1 · Siegel · 2016 [cited by applicant]
US 20160022198A1 · De Laat · 2016 [cited by applicant]
US 20160051354A1 · Patankar et al. · 2016 [cited by applicant]
US 20160074276A1 · Scheuring et al. · 2016 [cited by applicant]
US 20160121105A1 · Lee et al. · 2016 [cited by applicant]
US 20160279469A1 · Rose · 2016 [cited by applicant]
US 20160287887A1 · Wu et al. · 2016 [cited by applicant]
US 20160346610A1 · Iglesias et al. · 2016 [cited by applicant]
US 20170231709A1 · Gupta et al. · 2017 [cited by applicant]
US 20170281072A1 · Iglesias · 2017 [cited by applicant]
US 20170281299A1 · Iglesias · 2017 [cited by applicant]
US 20170291012A1 · Iglesias · 2017 [cited by applicant]
US 20170303843A1 · Iglesias · 2017 [cited by applicant]
US 20170312530A1 · Schilling et al. · 2017 [cited by applicant]
US 20170332959A1 · Bartlett · 2017 [cited by applicant]
US 20180021121A1 · Zeltwanger et al. · 2018 [cited by applicant]
US 20180146892A1 · Billard · 2018 [cited by applicant]
US 20180177458A1 · Burnett et al. · 2018 [cited by applicant]
US 20180199816A1 · Kalt et al. · 2018 [cited by applicant]
US 20190133738A1 · Rosen et al. · 2019 [cited by applicant]
US 20190160332A1 · Beer et al. · 2019 [cited by applicant]
US 20190288860A1 · Poltorak · 2019 [cited by applicant]
US 20200029812A1 · Govari et al. · 2020 [cited by applicant]
US 20200069161A1 · Schentag et al. · 2020 [cited by applicant]
US 20200146800A1 · Iglesias · 2020 [cited by applicant]
US 20200337888A1 · Beer et al. · 2020 [cited by applicant]
US 20200405142A1 · Whitaker · 2020 [cited by applicant]
US 20210069513A1 · Beer et al. · 2021 [cited by applicant]
US 20210106787A1 · Iglesias · 2021 [cited by applicant]
US 20210145353A1 · Iglesias · 2021 [cited by applicant]
US 20210161403A1 · Beer et al. · 2021 [cited by applicant]
US 20210321983A1 · Miyamoto · 2021 [cited by applicant]
US 20210353195A1 · Beer et al. · 2021 [cited by applicant]
US 20230026958A1 · Imran et al. · 2023 [cited by applicant]
US 20230201659A1 · Iglesias et al. · 2023 [cited by applicant]
US 20230201660A1 · Bohorquez et al. · 2023 [cited by applicant]
US 20230225847A1 · Iglesias · 2023 [cited by applicant]
CA 2625428A1 · 2007 [cited by applicant]
CA 2862928A1 · 2013 [cited by applicant]
CN 1408451A · 2003 [cited by applicant]
CN 103622710A · 2014 [cited by applicant]
CN 105120746A · 2015 [cited by applicant]
CN 204839545U · 2015 [cited by applicant]
CN 107205675A · 2017 [cited by applicant]
CN 107847196A · 2018 [cited by applicant]
DE 10345282B3 · 2005 [cited by applicant]
DE 202018103016U1 · 2018 [cited by applicant]
EP 0268972A2 · 1988 [cited by applicant]
EP 2689724A1 · 2014 [cited by applicant]
EP 2809231A4 · 2015 [cited by applicant]
EP 3366212A1 · 2018 [cited by applicant]
GB 2492754A · 2013 [cited by applicant]
JP 2002143133A · 2002 [cited by applicant]
JP 2008532578A · 2008 [cited by applicant]
JP 2011183167A · 2011 [cited by applicant]
RU 2307636C1 · 2007 [cited by applicant]
WO WO9605768A1 · 1996 [cited by applicant]
WO WO9905963A1 · 1999 [cited by applicant]
WO WO0009013A1 · 2000 [cited by applicant]
WO WO0023030A1 · 2000 [cited by applicant]
WO WO0137732A1 · 2001 [cited by applicant]
WO WO0217987A2 · 2002 [cited by applicant]
WO WO2003028572A1 · 2003 [cited by applicant]
WO WO2006107930A2 · 2006 [cited by applicant]
WO WO2007104152A2 · 2007 [cited by applicant]
WO WO2007136266A1 · 2007 [cited by applicant]
WO WO2010131252A2 · 2010 [cited by applicant]
WO WO2011050252A1 · 2011 [cited by applicant]
WO WO2011121591A2 · 2011 [cited by applicant]
WO WO2011159906A2 · 2011 [cited by applicant]
WO WO2012079127A1 · 2012 [cited by applicant]
WO WO2012138232A1 · 2012 [cited by applicant]
WO WO2013082006A1 · 2013 [cited by applicant]
WO WO2013115310A1 · 2013 [cited by applicant]
WO WO2013116310A1 · 2013 [cited by applicant]
WO WO2015103629A1 · 2015 [cited by applicant]
WO WO2016026914A2 · 2016 [cited by applicant]
WO WO2016042310A1 · 2016 [cited by applicant]
WO WO2016067023A1 · 2016 [cited by applicant]
WO WO2016119002A1 · 2016 [cited by applicant]
WO WO2016203485A1 · 2016 [cited by applicant]
WO WO2017149688A1 · 2017 [cited by applicant]
WO WO2018023037A1 · 2018 [cited by applicant]
WO WO2019084468A1 · 2019 [cited by applicant]
WO WO2019084469A1 · 2019 [cited by applicant]
WO WO2019200222A1 · 2019 [cited by applicant]
WO WO2019210204A1 · 2019 [cited by applicant]
WO WO2020092343A1 · 2020 [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 12852598.7, dated Jun. 6, 2018 (4 pages). [cited by applicant]
Examination Report for Canadian Patent Application No. 2,856,724, dated Oct. 18, 2018 (3 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 17203166.8, dated Jul. 31, 2018 (10 pages). [cited by applicant]
First Examination Report for Australian Patent Application No. 2017245476, dated Sep. 12, 2018 (3 pages). [cited by applicant]
First Examination Report for Australian Patent Application No. 2018200715, dated Jun. 26, 2018 (4 pages). [cited by applicant]
First Office Action for Mexican Patent Application No. MX/a/2014/006219, dated Jul. 31, 2017 (7 pages). [cited by applicant]
Glazer et al., “Pelvic floor muscle biofeedback in the treatment of urinary incontinence: A literature review,” Appl Psychophysiol Biofeedback. 31(3):187-201 (2006) (Abstract only). [cited by applicant]
[cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2017/044444, mailed Feb. 7, 2019 (14 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US17/44444, mailed Oct. 19, 2017 (21 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US18/57811, mailed Jan. 29, 2019 (18 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2012/066613, mailed Feb. 6, 2013 (5 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/027168, mailed Aug. 12, 2019 (39 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/029400, mailed Jul. 10, 2019 (17 pages). [cited by applicant]
Kandadai et al., “Correct Performance of Pelvic Muscle Exercises in Women Reporting Prior Knowledge,” Female Pelvic Med Reconstr Surg. 21(3):135-40 (2015). [cited by applicant]
Malcovati et al., Interface Circuitry and Microsystems. [cited by applicant]
Moen et al., “Pelvic floor muscle function in women presenting with pelvic floor disorders, ” Int Urogynecol J Pelvic Floor Dysfunct. 20(7):843-6 (2009). [cited by applicant]
Nygaard et al., “Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence,” Am J Obstet Gynecol. 174(1 Pt 1):120-125 (1996) (Abstract only). [cited by applicant]
Parekh et al., “The role of pelvic floor exercises on post-prostatectomy incontinence,” J Urol. 170(1):130-33 (2003) (Abstract Only) (2 pages). [cited by applicant]
Rosenbaum et al., “The Role of Pelvic Floor Physical Therapy in the Treatment of Pelvic and Genital Pain-Related Sexual Dysfunction,” J Sex Med. 5(3): 513-23 (2008). [cited by applicant]
Rosenbaum, “Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: a literature review,” J Sex Med. 4(1):4-13 (2007) (Abstract only) (2 pages). [cited by applicant]
Rosenblatt et al., “Evaluation of an accelerometer-based digital health system for the treatment of female urinary incontinence: A pilot study,” Neurourol Urodyn. 38(7): 1944-1952 (2019). [cited by applicant]
Rosenblatt et al., “Interactive Pelvic Floor Muscle Training for Female Urinary Incontinence,” Renovia, Inc., retrieved Apr. 30, 2019 from <renoviainc.com/wp-content/uploads/2018/04/REN005.01-White-Paper-12Apr18-FINAL.p… [cited by applicant]
Second Examination Report for Canadian Patent Application No. 2,862,928, dated Nov. 20, 2018 (5 pages). [cited by applicant]
[cited by applicant]
Summons to attend oral proceedings pursuant to Rule 115(1) EPC, issued on Aug. 3, 2017 by the European Patent Office related to the European Patent Application No. 13743383.5 (10 pages). [cited by applicant]
Office Action for Chinese Patent Application No. 201880083895.6, dated Feb. 8, 2022 (24 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/058527, mailed Feb. 21, 2020 (18 pages). [cited by applicant]
Office Action for Japanese Patent Application No. 2019-504938, dated May 18, 2021 (10 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2021/033155, mailed Aug. 25, 2021 (19 pages). [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 15733078.8, dated Aug. 24, 2021 (8 pages). [cited by applicant]
Office Action for Japanese Patent Application No. 2020-143711, dated Sep. 8, 2021 (4 pages). [cited by applicant]
First Examination Report for Australian Patent Application No. 2020281099, dated Nov. 2, 2021 (6 pages). [cited by applicant]
Office Action for Brazilian Patent Application No. BR112019001746-1, dated Dec. 10, 2021 (5 pages). [cited by applicant]
Extended European Search Report for European Application No. 19793343.5, dated Jan. 27, 2022 (7 pages). [cited by applicant]
Notice of Preliminary Rejection for Korean Patent Application No. 10-2019-7005863, dated Jan. 26, 2022 (17 pages). [cited by applicant]
Office Action for Chinese Patent Application No. 201780060078.4, issued Jan. 17, 2022 (20 pages). [cited by applicant]
Office Action for Japanese Patent Application No. 2019-504938 dated Feb. 8, 2022 (13 pages). [cited by applicant]
U.S. Appl. No. 18/157,453, Iglesias. [cited by applicant]
U.S. Appl. No. 17/822,954, Iglesias et al. [cited by applicant]
U.S. Appl. No. 17/926,192, Bohorquez et al. [cited by applicant]
Extended European Search Report for European Patent Application No. 19786241.0, dated Apr. 29, 2022 (10 pages). [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2020-143711, mailed May 9, 2022 (7 pages). [cited by applicant]
Office Action for Chinese Patent Application No. 201780060078.4, issued Apr. 13, 2022 (19 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 19878836.6, dated Jun. 1, 2022 (7 pages). [cited by applicant]
Office Action for Canadian Patent Application No. 2,936,061, dated Jun. 23, 2022 (4 pages). [cited by applicant]
Notice of Last Preliminary Rejection for Korean Patent Application No. 10-2019-7005863, dated Jul. 28, 2022 (4 pages). [cited by applicant]
Office Action for Brazilian Patent Application No. BR112020008231-7, dated Sep. 7, 2022 (5 pages) (Informal translation of Office Action included). [cited by applicant]
Extended European Search Report dated Aug. 16, 2017 issued in related EP Application No. 15733078.8 filed Aug. 2, 2016 (6 pages). [cited by applicant]
International Search Report and Written Opinion, dated Mar. 26, 2015, issued in International Application No. PCT/US2015/010356, filed on Jan. 6, 2015 (5 pages). [cited by applicant]
Office Action for Chinese Patent Application No. 201880083895.6 dated Oct. 25, 2022 (8 pages). [cited by applicant]
Office Action for European Patent Application No. 17203166.8, dated Aug. 29, 2023 (6 pages). [cited by applicant]
Extended European Search Report for European Patent Application No. 21808988.6, dated Apr. 25, 2024 (9 pages). [cited by applicant]
Ezra et al., “Patterns of tined lead migration in sacral nerve modulation,” International Journal of Colorectal Disease. 35:1163-1166 (Mar. 2020). [cited by applicant]
Dudding et al., “Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice,” Technology at the Neural Interface Neuromodulation. 24: 1247-1257 (Jun. 2021). [cited by applicant]
Husk et al., “Variation in bony landmarks and predictors of success with sacral neuromodulation,” International Urogynecology Journal. 30:1973-1979 (Feb. 2019). [cited by applicant]
Powell, “Troubleshooting Interstim Sacral Neuromodulation Generators to Recover Function,” Current Urology Reports. 19:86 (Aug. 2018) (9 pages). [cited by applicant]